Comparison of different laboratory tests in the evaluation of hemorrhagic risk of patients using rivaroxaban in the critical care setting: diagnostic accuracy study
Abstract Background Rivaroxaban is a direct oral anticoagulant designed to dispense with the necessity of laboratory monitoring. However, monitoring rivaroxaban levels is necessary in certain clinical conditions, especially in the critical care setting. Methods This is a diagnostic accuracy study ev...
Main Authors: | Marjorie Paris Colombini, Priscilla Bento Matos Cruz Derogis, Valdir Fernandes de Aranda, João Carlos de Campos Guerra, Nelson Hamerschlak, Cristóvão Luis Pitangueiras Mangueira |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12959-017-0140-6 |
Similar Items
-
Evaluation of the effect of apixaban using a viscoelastic coagulation assay with Russell’s viper venom reagent
by: Kaoru Suzuki, et al.
Published: (2021-05-01) -
A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
by: Tomas L. Lindahl, et al.
Published: (2017-07-01) -
The discovery of rivaroxaban: translating preclinical assessments into clinical practice
by: Dagmar eKubitza, et al.
Published: (2013-11-01) -
Estimation of Antiphospholipid Antibodies, Anticardiolipin Antibodies, Beta-2 Glycoprotein 1 Antibodies in Recurrent Pregnancy Loss - A Case-control Study
by: Nilam Bhasker, et al.
Published: (2018-10-01) -
Current Controversies in Lupus Anticoagulant Detection
by: Gary W. Moore
Published: (2016-12-01)